A 52-year-old woman with newly diagnosed chronic myeloid leukemia (CML) in chronic phase presents to the hematology clinic. Cytogenetics confirm the Philadelphia chromosome t(9;22). Which is the drug of choice for first-line treatment?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.